Professor Rodgers has a track record in cardiovascular disease prevention, innovation and public-private partnerships, with an interest in scale-able interventions to address major risks to health. He is currently Acting Director of the Cardiovascular Division at The George Institute, Australia and Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London.

After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Professor Rodgers has led developments of an affordable four-in-one cardiovascular combination pill ('polypill'). He led a clinical trial program in economically developed and developing countries, funded by the Wellcome Trust, European Union and others.  

Professor Rodgers also developed a world first cell phone based smoking cessation programme for youth, which disseminated proven health support messages in an age-appropriate, affordable medium.  Over 6,000 patients were involved in clinical trials that demonstrated a 50% increase in quit rates. The service has been rolled out by Departments of Health in NZ, UK and India, with over 2 million users to date. A follow-on program delivering cognitive behavioural therapy for depression prevention was successfully trialled among 1,200 at-risk teenagers.

Julie Brown heads the Injury Program at The George Institute for Global Health, Australia, is Co-Director of the Transurban Road Safety Centre at NeuRA, and Professor, School of Population Health, UNSW Sydney. She works across the continuum of the public health model from defining problems, identifying risk and protective factors, developing and testing interventions to monitoring and evaluating the implementation of interventions designed to reduce the burden of injury, and has demonstrated expertise in multi-disciplinary research methods. Her career vision is to reduce the health burden attributable to injury by delivering tangible ways to prevent road crash-related injury and unintentional injury more broadly. Prior to completing her PhD at UNSW in 2008, she worked for >20 years in vehicle and equipment safety research and policy development for the NSW government. Insight into research needs for regulatory and policy development from this experience continues to frame her research.

Maarinke is the Program Lead for the Global Thought Leadership Program, in the Impact and Engagement team. She is an innovation specialist, translating research insights for different audiences into a range of formats and complimenting advocacy efforts on preventable disease and injury. Maarinke is particularly interested in finding links between silos, working across specialisations, and connecting people and ideas, joining skills and expertise to deliver strong outcomes.

Maarinke joined the George Institute in 2018, establishing activities such as data visualisation, interactive stories and podcasts. Since then, Maarinke has further developed The Global Thought Leadership program, designing the Emerging Thought Leader Program - a 6 month capacity strengthening program to train and coach early-mid career researchers and subject matter experts- as well as the Distinguished Fellow Program, engaging and collaborating on thought leadership activities with a network of renowned experts around the globe.

Prior to working at The George Institute, Maarinke worked in other technical industries, including medicines education, insurance, finance and IT. Maarinke has a Masters in International Law and International Relations, Graduate Certificate in Health Policy and Health Communications, and a Bachelor of Business with double major in Marketing and Management.